Terence A. Kelly, Ph.D., Joins CoMentis, Inc. as Senior Vice President for Discovery and Preclinical Development
7/12/2010 10:59:55 AM
More...
|
CoMentis, Inc. and Astellas Pharma Inc. to Present Alzheimer's Disease Research at International Conference on Alzheimer's Disease (ICAD)
7/28/2008 9:36:34 AM
More...
|
New Alzheimer's Treatment Completes First Phase Of Testing
1/28/2008 7:42:09 AM
More...
|
CoMentis, Inc. Announces Proof-of-Activity Data From Its Phase I Study of Disease-Modifying Alzheimer's Disease Therapy
1/8/2008 9:57:57 AM
More...
|
CoMentis, Inc. Announces Appointment of John L. Higgins to Board of Directors
1/8/2008 9:56:48 AM
More...
|
Juvenile Diabetes Research Foundation Partners with CoMentis, Inc. for Diabetic Macular Edema Clinical Trial
9/20/2007 1:30:00 PM
More...
|
Juvenile Diabetes Research Foundation Partners With CoMentis, Inc. for Diabetic Macular Edema Clinical Trial
9/20/2007 8:41:25 AM
More...
|
CoMentis, Inc. Receives FDA Clearance to Begin Human Clinical Trials for Its Disease-Modifying Alzheimer's Therapy
6/18/2007 10:34:22 AM
More...
|
CoMentis, Inc. Announces Appointment of Martin Tolar, M.D., Ph.D., as Vice President of Strategic and Corporate Development
6/6/2007 10:18:50 AM
More...
|
CoMentis, Inc. Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
4/10/2007 4:06:00 PM
More...
|